SHARE THIS VIDEO —
Study Says Drug Cuts Cholesterol and Reduces Heart Attacks - But It’s Not Cheap
A study paid for by the drug maker of Repatha found that it can have huge benefits on patients, but the price tag is steep: $14,000 per year.
we and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences. by using the site, you consent to these cookies. for more information on cookies including how to manage your consent visit our cookie policy.